Table of Contents
Hepatitis Research and Treatment
Volume 2013, Article ID 149247, 4 pages
http://dx.doi.org/10.1155/2013/149247
Research Article

Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients

1Psychiatry and Inflammation Program, Department of Psychiatry, Tufts Medical Center, Tufts University, Boston, MA 02111, USA
2Department of Experimental and Clinical Pharmacology, Medical University, 20-090 Lublin, Poland
3Department of Toxicology, Institute of Rural Health, 20-090 Lublin, Poland
4Division of Gastroenterology/Hepatology, Tufts Medical Center, Tufts University, Boston, MA 02111, USA

Received 30 June 2013; Revised 5 August 2013; Accepted 7 August 2013

Academic Editor: Alessandro Antonelli

Copyright © 2013 G. F. Oxenkrug et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Romero-Gómez, “Insulin resistance and hepatitis C,” World Journal of Gastroenterology, vol. 12, no. 44, pp. 7075–7080, 2006. View at Google Scholar · View at Scopus
  2. R. Moucari, T. Asselah, D. Cazals-Hatem et al., “Insulin Resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis,” Gastroenterology, vol. 134, no. 2, pp. 416–423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. S. Conjeevaram, A. S. Wahed, N. Afdhal, C. D. Howell, J. E. Everhart, and J. H. Hoofnagle, “Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C,” Gastroenterology, vol. 140, no. 2, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. Huang, M. L. Yu, C. Y. Dai et al., “Glucose abnormalities in hepatitis C virus infection,” Kaohsiung Journal of Medical Sciences, vol. 29, no. 2, pp. 61–68, 2013. View at Publisher · View at Google Scholar
  5. A. Shlomai, M. Mouler, E. Rechtma et al., “The metabolic regulator PGC-1a links hepatitis C virus infection to hepatic insulin resistance,” Journal of Hepatology, vol. 57, pp. 867–873, 2012. View at Google Scholar
  6. A. Lecube, C. Hernández, J. Genescà et al., “Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study,” Diabetes Care, vol. 29, no. 5, pp. 1096–1101, 2006. View at Google Scholar
  7. N. Tanaka, T. Nagaya, M. Komatsu et al., “Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase,” Liver International, vol. 28, no. 8, pp. 1104–1111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Robinson, P. T. Hale, and J. M. Carlin, “The role of IFN-γ and TNF-α-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase,” Journal of Interferon and Cytokine Research, vol. 25, no. 1, pp. 20–30, 2005. View at Google Scholar · View at Scopus
  9. K. Higashitani, T. Kanto, S. Kuroda et al., “Association of enhanced activity of indoleamine 2, 3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection,” Journal of Gastroenterology, vol. 48, no. 5, pp. 660–670, 2013. View at Google Scholar
  10. E. Larrea, J. I. Riezu-Boj, L. Gil-Guerrero et al., “Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection,” Journal of Virology, vol. 81, no. 7, pp. 3662–3666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Connick and T. W. Stone, “The role of kynurenines in diabetes mellitus,” Medical Hypotheses, vol. 18, no. 4, pp. 371–376, 1985. View at Google Scholar · View at Scopus
  12. G. Oxenkrug, “Insulin resistance and dysregulation of tryptophan—kynurenine and kynurenine—nicotinamide adenine dinucleotide metabolic pathways,” Molecular Neurobiology, 2013. View at Publisher · View at Google Scholar
  13. K. Schroecksnadel, B. Frick, C. Winkler, and D. Fuchs, “Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease,” Current Vascular Pharmacology, vol. 4, no. 3, pp. 205–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Cozzi, A. L. Zignego, R. Carpendo et al., “Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients,” Journal of Viral Hepatitis, vol. 13, no. 6, pp. 402–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. A. Turski, M. Nakamura, W. P. Todd, B. K. Carpenter, W. O. Whetsell Jr., and R. Schwarcz, “Identification and quantification of kynurenic acid in human brain tissue,” Brain Research, vol. 454, no. 1-2, pp. 164–169, 1988. View at Google Scholar · View at Scopus
  16. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. . Schwarcz, J. P. Bruno, and P. J. Muchowski, “Kynurenines in the mammalian brain: when physiology meets pathology,” Nature Reviews Neuroscience, vol. 13, no. 7, pp. 465–477, 2012. View at Publisher · View at Google Scholar
  18. G. F. Oxenkrug, “Genetic and hormonal regulation of tryptophan—kynurenine metabolism implications for vascular cognitive impairment, major depressive disorder, and aging,” Annals of the New York Academy of Sciences, vol. 1122, pp. 35–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. Koopmans, M. Ruis, R. Dekker, and M. Korte, “Surplus dietary tryptophan inhibits stress hormone kinetics and induces insulin resistance in pigs,” Physiology and Behavior, vol. 98, no. 4, pp. 402–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. K. Munipally, S. G. Agraharm, V. K. Valavala, S. Gundae, and N. R. Turlapati, “Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients,” Archives of Physiology and Biochemistry, vol. 117, no. 5, pp. 254–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Noto and H. Okamoto, “Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets,” Acta Diabetologica Latina, vol. 15, no. 5-6, pp. 273–282, 1978. View at Google Scholar · View at Scopus
  22. K. S. Rogers and S. J. Evangelista, “3-hydroxykynurenine, 3-hydroxyanthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets,” Proceedings of the Society for Experimental Biology and Medicine, vol. 178, no. 2, pp. 275–278, 1985. View at Google Scholar · View at Scopus
  23. D. Kuc, W. Zgrajka, J. Parada-Turska, T. Urbanik-Sypniewska, and W. A. Turski, “Micromolar concentration of kynurenic acid in rat small intestine,” Amino Acids, vol. 35, no. 2, pp. 503–505, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hattori, Y. Kotake, and Y. Kotake, “Studies on the urinary excretion of xanthurenic acid in diabetics,” Acta Vitaminologica et Enzymologica, vol. 6, no. 3, pp. 221–228, 1984. View at Google Scholar · View at Scopus
  25. Y. Kotake, T. Ueda, and T. Mori, “Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA),” Acta Vitaminologica et Enzymologica, vol. 29, no. 1–6, pp. 236–239, 1975. View at Google Scholar · View at Scopus
  26. S. Ikeda and Y. Kotake, “Urinary excretion of xanthurenic acid and zinc in diabetes: (3) occurrence of xanthurenic acid-Zn2+ complex in urine of diabetic patients and of experimentally-diabetic rats,” Italian Journal of Biochemistry, vol. 35, no. 4, pp. 232–241, 1986. View at Google Scholar · View at Scopus
  27. G. Meyramov, V. Korchin, and N. Kocheryzkina, “Diabetogenic activity of xanturenic acid determined by its chelating properties,” Transplantation Proceedings, vol. 30, no. 6, pp. 2682–2684, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Z. Malina, C. Richter, M. Mehl, and O. M. Hess, “Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown,” BMC Physiology, vol. 1, no. 1, pp. 7–11, 2001. View at Google Scholar · View at Scopus
  29. Q. Wang, J. Chen, Y. Wang et al., “Hepatitis C virus induced a novel apoptosis like death of pancreatic beta cells through a caspase 3-dependent pathway,” PLoS ONE, vol. 7, no. 6, Article ID e38522, 2012. View at Publisher · View at Google Scholar
  30. D. A. Bender, E. N. M. Njagi, and P. S. Danielian, “Tryptophan metabolism in vitamin B6-deficient mice,” British Journal of Nutrition, vol. 63, no. 1, pp. 27–36, 1990. View at Google Scholar · View at Scopus
  31. C. C. Lin and M. C. Yin, “Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin,” Clinical Nutrition, vol. 28, no. 1, pp. 34–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. F. Helaly, N. G. Hussein, W. Refai, and M. Ibrahim, “Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance,” Translational Research, vol. 158, no. 3, pp. 155–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Trpkovic, E. Stokic, D. Radak, S. Mousa, D. P. Mikhailidis, and E. R. Isenovic, “Chronic hepatitis C, insulin resistance and vascular disease,” Current Pharmaceutical Design, vol. 16, no. 34, pp. 3823–3829, 2010. View at Google Scholar · View at Scopus